Pfizer Global Medical Grants: Antimicrobial Stewardship and AMR is a competitive grant program from Pfizer Inc. that funds independent initiatives — including research, quality improvement, and education — aimed at improving patient outcomes in antimicrobial stewardship and combating antimicrobial resistance (AMR). Pfizer publishes Requests for Proposals (RFPs) outlining specific gaps in research, practice, or care, and invites organizations to apply. Grantees are responsible for the design, implementation, and conduct of their initiatives. Eligible applicants include medical centers, universities, and healthcare organizations globally. Awards typically range from $50,000 to $250,000. Applications are reviewed on a rolling RFP basis — check Pfizer's grants portal for current open solicitations.

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.